展示出強大的臨床表現並為患者帶來益處的先進藥物。
自成立以来，艾伯维一直位居制药行业全球创新排名前列。 2020 年，研发投入达 58 亿美元。我们的治疗产品线前景广阔：未来几年，我们将在免疫学、病毒学、神经学和肿瘤学领域进行创新。
您可以在这里找到我们管道的概述：
艾伯维管道 (abbvie.com)
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?
